Cargando…

A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects

Compound heterozygous (CH) variants occur when two recessive alleles are inherited and the variants are located at different loci within the same gene in a given individual. CH variants are important contributors to many different types of recessively inherited diseases. However, many studies overlo...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Dustin B., Piccolo, Stephen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019969/
https://www.ncbi.nlm.nih.gov/pubmed/33828584
http://dx.doi.org/10.3389/fgene.2021.640242
_version_ 1783674488980766720
author Miller, Dustin B.
Piccolo, Stephen R.
author_facet Miller, Dustin B.
Piccolo, Stephen R.
author_sort Miller, Dustin B.
collection PubMed
description Compound heterozygous (CH) variants occur when two recessive alleles are inherited and the variants are located at different loci within the same gene in a given individual. CH variants are important contributors to many different types of recessively inherited diseases. However, many studies overlook CH variants because identification of this type of variant requires knowing the parent of origin for each nucleotide. Using computational methods, haplotypes can be inferred using a process called “phasing,” which estimates the chromosomal origin of most nucleotides. In this paper, we used germline, phased, whole-genome sequencing (WGS) data to identify CH variants across seven pediatric diseases (adolescent idiopathic scoliosis: n = 16, congenital heart defects: n = 709, disorders of sex development: n = 79, ewing sarcoma: n = 287, neuroblastoma: n = 259, orofacial cleft: n = 107, and syndromic cranial dysinnervation: n = 172), available as parent-child trios in the Gabriella Miller Kids First Data Resource Center. Relatively little is understood about the genetic underpinnings of these diseases. We classified CH variants as “potentially damaging” based on minor allele frequencies (MAF), Combined Annotation Dependent Depletion scores, variant impact on transcription or translation, and gene-level frequencies in the disease group compared to a healthy population. For comparison, we also identified homozygous alternate (HA) variants, which affect both gene copies at a single locus; HA variants represent an alternative mechanism of recessive disease development and do not require phasing. Across all diseases, 2.6% of the samples had a potentially damaging CH variant and 16.2% had a potentially damaging HA variant. Of these samples with potentially damaging variants, the average number of genes per sample was 1 with a CH variant and 1.25 with a HA variant. Across all samples, 5.1 genes per disease had a CH variant, while 35.6 genes per disease had a HA variant; on average, only 4.3% of these variants affected common genes. Therefore, when seeking to identify potentially damaging variants of a putatively recessive disease, CH variants should be considered as potential contributors to disease development. If CH variants are excluded from analysis, important candidate genes may be overlooked.
format Online
Article
Text
id pubmed-8019969
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80199692021-04-06 A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects Miller, Dustin B. Piccolo, Stephen R. Front Genet Genetics Compound heterozygous (CH) variants occur when two recessive alleles are inherited and the variants are located at different loci within the same gene in a given individual. CH variants are important contributors to many different types of recessively inherited diseases. However, many studies overlook CH variants because identification of this type of variant requires knowing the parent of origin for each nucleotide. Using computational methods, haplotypes can be inferred using a process called “phasing,” which estimates the chromosomal origin of most nucleotides. In this paper, we used germline, phased, whole-genome sequencing (WGS) data to identify CH variants across seven pediatric diseases (adolescent idiopathic scoliosis: n = 16, congenital heart defects: n = 709, disorders of sex development: n = 79, ewing sarcoma: n = 287, neuroblastoma: n = 259, orofacial cleft: n = 107, and syndromic cranial dysinnervation: n = 172), available as parent-child trios in the Gabriella Miller Kids First Data Resource Center. Relatively little is understood about the genetic underpinnings of these diseases. We classified CH variants as “potentially damaging” based on minor allele frequencies (MAF), Combined Annotation Dependent Depletion scores, variant impact on transcription or translation, and gene-level frequencies in the disease group compared to a healthy population. For comparison, we also identified homozygous alternate (HA) variants, which affect both gene copies at a single locus; HA variants represent an alternative mechanism of recessive disease development and do not require phasing. Across all diseases, 2.6% of the samples had a potentially damaging CH variant and 16.2% had a potentially damaging HA variant. Of these samples with potentially damaging variants, the average number of genes per sample was 1 with a CH variant and 1.25 with a HA variant. Across all samples, 5.1 genes per disease had a CH variant, while 35.6 genes per disease had a HA variant; on average, only 4.3% of these variants affected common genes. Therefore, when seeking to identify potentially damaging variants of a putatively recessive disease, CH variants should be considered as potential contributors to disease development. If CH variants are excluded from analysis, important candidate genes may be overlooked. Frontiers Media S.A. 2021-03-22 /pmc/articles/PMC8019969/ /pubmed/33828584 http://dx.doi.org/10.3389/fgene.2021.640242 Text en Copyright © 2021 Miller and Piccolo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Miller, Dustin B.
Piccolo, Stephen R.
A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects
title A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects
title_full A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects
title_fullStr A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects
title_full_unstemmed A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects
title_short A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects
title_sort survey of compound heterozygous variants in pediatric cancers and structural birth defects
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019969/
https://www.ncbi.nlm.nih.gov/pubmed/33828584
http://dx.doi.org/10.3389/fgene.2021.640242
work_keys_str_mv AT millerdustinb asurveyofcompoundheterozygousvariantsinpediatriccancersandstructuralbirthdefects
AT piccolostephenr asurveyofcompoundheterozygousvariantsinpediatriccancersandstructuralbirthdefects
AT millerdustinb surveyofcompoundheterozygousvariantsinpediatriccancersandstructuralbirthdefects
AT piccolostephenr surveyofcompoundheterozygousvariantsinpediatriccancersandstructuralbirthdefects